All stocks Β· GAUDIUMIVF
GI

Gaudium IVF and Women Health Limited

GAUDIUMIVF BSE Medical Care Facilities Healthcare

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauteri…

ISIN INE0P8B01020
Listed β€”
Quarters tracked 7
Filings 6 docs

About

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; infertility surgeries; egg freezing; surrogacy; and laparoscopic and hysteroscopic surgeries for the diagnosis and treatment of infertility-related conditions, as well as offers genetic testing options, including preimplantation genetic testing (PGT); and IVF consultancy services. In addition, the company operates hospital, in-house pharmacy; and 7 hubs (IVF centers) and 28 spokes. The company was founded in 2009 and is based in headquartered in New Delhi, India.

Key Metrics

as of Sep 2026
Market Cap845 Cr
P/E36.50
Div Yield0.00 %
Book Valueβ‚Ή20.90
52w Highβ‚Ή164.00
52w Lowβ‚Ή69.20
Face Valueβ‚Ή5.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024
Sales 13.68 22.17 14.19 22.95 12.27 16.82 13.95
Expenses 11.50 10.91 8.36 9.67 8.11 8.54 8.37
Operating Profit 2.18 11.26 5.83 13.28 4.16 8.28 5.58
OPM % 15.94 50.79 41.09 57.86 33.90 49.23 40.00
Other Income 1.12 0.18 0.10 0.12 0.00 0.23 0.00
Depreciation 0.68 0.61 0.47 0.59 0.58 0.36 0.57
Interest 0.32 1.24 1.12 0.51 0.50 0.43 0.39
Profit before tax 2.30 9.59 4.34 12.30 3.08 7.72 4.62
Tax % 27.83 19.40 26.73 26.67 23.38 19.69 27.71
Net Profit 1.66 7.73 3.18 9.03 2.35 6.21 3.35
EPS in Rs 0.23 1.06 0.52 1.47 0.38 1.01 0.55

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023
Sales 72.0059.0046.0044.00
Expenses 37.0031.0027.0024.00
Operating Profit 35.0028.0019.0020.00
OPM % 48.0048.0041.0045.00
Other Income 0.000.000.000.00
Interest 3.002.001.000.00
Depreciation 2.002.002.001.00
Profit before tax 29.0025.0016.0018.00
Tax % 24.0025.0038.0026.00
Net Profit 22.0019.0010.0013.00
EPS in Rs 3.063.03100.28133.91
Dividend Payout % 0.000.000.0048.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023
Equity Capital 36.0031.000.990.99
Reserves 113.0015.0026.0022.00
Borrowings 23.0021.0017.0010.00
Other Liabilities 7.009.007.002.00
Total Liabilities 179.0075.0051.0035.00
Fixed Assets 27.0018.0018.0016.00
CWIP 0.007.000.000.00
Investments 6.006.001.001.00
Other Assets 145.0044.0031.0018.00
Total Assets 179.0075.0051.0035.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023
Cash from Operating Activity 7.008.003.0024.00
Cash from Investing Activity -86.00-15.00-5.00-14.00
Cash from Financing Activity 80.002.00-1.004.00
Net Cash Flow 2.00-5.00-3.0013.00
Free Cash Flow 3.000.001.0011.00
CFO/OP % 53.0046.0028.00145.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023
Debtor Days 217.00146.00108.007.00
Inventory Days 177.00170.00141.00101.00
Days Payable 217.0099.0085.0083.00
Cash Conversion Cycle 176.00218.00164.0026.00
Working Capital Days 124.0046.00-22.00-54.00
ROCE % 27.0048.0044.00β€”

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026
Promoters 71.29 71.29
FIIs 3.01 6.70
DIIs 2.22 2.63
Public 23.47 19.39
No. of Shareholders 21,910 19,854

Corporate Actions

No corporate actions recorded.

Announcements

5 filings